Apalutamide for prostate cancer: Multicentre and multidisciplinary real-world study of 227 patients.
Sánchez JC, Picola N, Rodriguez-Vida A, Costa M, Castañeda DM, Márquez MP, Rodriguez JM, Gaya JM, Bravo A, Buisan O, Servian P, Suarez JF, Felip MM, Caparrós MJR, Asensio AA, Vilaseca A.
Sánchez JC, et al. Among authors: vilaseca a.
Cancer Med. 2023 Dec;12(24):21969-21977. doi: 10.1002/cam4.6769. Epub 2023 Dec 8.
Cancer Med. 2023.
PMID: 38063364
Free PMC article.